Johnson & Johnson director granted 1,712 DSUs

Pinto Daniel E reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Pinto Daniel E reported acquisition or exercise transactions in this Form 4 filing.

Johnson & Johnson director Daniel E. Pinto received a grant of 1,712 Deferred Share Units (DSUs). These DSUs were awarded under the company’s Amended and Restated Deferred Fee Plan for Directors and are a form of non-cash director compensation.

After this grant, Pinto holds a total of 2,174.069 DSUs. According to the disclosure, these DSUs will be settled in cash when his board service ends, with each unit representing the fair market value of one share of Johnson & Johnson common stock on the settlement date. The total also reflects dividend equivalent rights that accrue on DSUs in connection with the company’s quarterly dividends.

Insider Trade Summary

Grant/Award: 1,712 shares

Grant/Award 1 txn

Insider Pinto Daniel E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units	1,712	$0.00	$0.00

Holdings After Transaction: Deferred Share Units — 2,174.069 contracts (Direct)

Footnotes (2)

1. F1. Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
2. F2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Key Figures

Deferred Share Units granted: 1,712 units Total DSUs after grant: 2,174.069 units Transaction price per unit: $0.0000 +1 more

4 metrics

Deferred Share Units granted 1,712 units Grant of DSUs to Daniel E. Pinto on April 23, 2026

Total DSUs after grant 2,174.069 units Deferred Share Units held by Daniel E. Pinto following transaction

Transaction price per unit $0.0000 Compensation award, no cash paid by reporting person

Underlying security 1,712 shares of Common Stock Each DSU corresponds to one share’s fair market value at settlement

Key Terms

Deferred Share Units, Amended and Restated Deferred Fee Plan for Directors, dividend equivalent rights

3 terms

Deferred Share Units financial

"Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors"

Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.

Amended and Restated Deferred Fee Plan for Directors financial

"acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors"

dividend equivalent rights financial

"Includes dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Johnson & Johnson (JNJ) director Daniel Pinto report on this Form 4?

Daniel E. Pinto reported receiving 1,712 Deferred Share Units as a compensation award. These DSUs increase his total holdings to 2,174.069 units and are part of Johnson & Johnson’s director deferred fee plan, settling in cash at the end of his board service.

How many Deferred Share Units does Daniel Pinto hold at Johnson & Johnson (JNJ) after this transaction?

Following the reported grant, Daniel Pinto holds 2,174.069 Deferred Share Units. This total includes the newly awarded 1,712 units plus previously held DSUs and related dividend equivalent rights that accumulate alongside Johnson & Johnson’s regular quarterly dividends.

Are the Johnson & Johnson (JNJ) Deferred Share Units received by Daniel Pinto settled in stock or cash?

The Deferred Share Units reported by Daniel Pinto are settled in cash, not stock. Upon termination of his directorship, each DSU will pay an amount equal to the fair market value of one Johnson & Johnson common share on the settlement date.

What does the Form 4 say about dividend equivalent rights on Daniel Pinto’s Johnson & Johnson (JNJ) DSUs?

The filing notes that Pinto’s DSUs include dividend equivalent rights. These rights accrue in connection with Johnson & Johnson’s quarterly dividend, effectively increasing his DSU balance over time to mirror the impact of dividends on common shareholders.

Is Daniel Pinto’s Johnson & Johnson (JNJ) Form 4 transaction an open-market stock purchase or sale?

No, the Form 4 shows a compensation-related acquisition, not a market trade. Daniel Pinto received 1,712 Deferred Share Units as a grant under Johnson & Johnson’s director deferred fee plan, with no cash paid and no open-market buying or selling.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 06:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pinto Daniel E

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NEW JERSEY 08933

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	04/23/2026		A		1,712		(1)	(1)	Common Stock	1,712	$0	2,174.069(2)	D

Explanation of Responses:

1. Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Daniel E. Pinto	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)